Aurobindo Pharma’s wholly owned subsidiary (WOS) -- Curateq Biologics has incorporated a new wholly owned subsidiary in the Netherlands by the name of CuraTeQ Biologics B.V. The newly incorporated entity belongs to biopharma products industry. The object of incorporation of this WOS is to expand the biopharma products business in Europe.
Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.
